These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22410513)

  • 21. [New therapeutic approaches in the treatment of retinopathy of prematurity].
    Jandeck C
    Klin Monbl Augenheilkd; 2009 Nov; 226(11):914-20. PubMed ID: 19798624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms of Vascular Endothelial Growth Factor and Retinopathy of Prematurity.
    Ali AA; Hussien NF; Samy RM; Husseiny KA
    J Pediatr Ophthalmol Strabismus; 2015; 52(4):245-53. PubMed ID: 25992764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pathogenesis of retinopathy of prematurity.
    Smith LE
    Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S140-4. PubMed ID: 15135797
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The treatment and risk factors of retinopathy of prematurity in neonatal intensive care units.
    Leng Y; Huang W; Ren G; Cai C; Tan Q; Liang Y; Yang W; Gao Z
    BMC Ophthalmol; 2018 Nov; 18(1):301. PubMed ID: 30458733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Laser treatment or intravitreal VEGF inhibition for aggressive posterior retinopathy of prematurity?].
    Barth T; Hufendiek K; Helbig H; Oberacher-Velten I
    Ophthalmologe; 2015 Jun; 112(6):520-4. PubMed ID: 25573085
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retinopathy of prematurity: New developments bring concern and hope.
    Darlow BA
    J Paediatr Child Health; 2015 Aug; 51(8):765-70. PubMed ID: 25757043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravitreal pegaptanib combined with diode laser therapy for stage 3+ retinopathy of prematurity in zone I and posterior zone II.
    Autrata R; Krejcírová I; Senková K; Holoušová M; Doležel Z; Borek I
    Eur J Ophthalmol; 2012; 22(5):687-94. PubMed ID: 22669848
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-Vascular Endothelial Growth Factor Therapy for Primary Treatment of Type 1 Retinopathy of Prematurity: A Report by the American Academy of Ophthalmology.
    VanderVeen DK; Melia M; Yang MB; Hutchinson AK; Wilson LB; Lambert SR
    Ophthalmology; 2017 May; 124(5):619-633. PubMed ID: 28341474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retinopathy of prematurity: do we still have a problem?: the Charles L. Schepens lecture.
    Tasman W
    Arch Ophthalmol; 2011 Aug; 129(8):1083-6. PubMed ID: 21825195
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Longitudinal postnatal weight and insulin-like growth factor I measurements in the prediction of retinopathy of prematurity.
    Löfqvist C; Andersson E; Sigurdsson J; Engström E; Hård AL; Niklasson A; Smith LE; Hellström A
    Arch Ophthalmol; 2006 Dec; 124(12):1711-8. PubMed ID: 17159030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lack of association between vascular endothelial growth factor and retinopathy of prematurity in an observational study.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2202-2208. PubMed ID: 28573924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevention of blindness due to retinopathy of prematurity: a national movement.
    Azad R
    Indian J Pediatr; 2014 Dec; 81(12):1373-5. PubMed ID: 24794325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging treatments for retinopathy of prematurity.
    Mantagos IS; Vanderveen DK; Smith LE
    Semin Ophthalmol; 2009; 24(2):82-6. PubMed ID: 19373691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Management of retinopathy of prematurity.
    Fleck BW
    Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F454-6. PubMed ID: 23813885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Advances in Retinopathy of Prematurity].
    Xu XX; Wu YJ; Wu HY; Hu YX; Cheng Y; Yan L; Rao J; Wu N; Wu XR
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):261-266. PubMed ID: 31060684
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Understanding retinopathy of prematurity: update on pathogenesis.
    Rivera JC; Sapieha P; Joyal JS; Duhamel F; Shao Z; Sitaras N; Picard E; Zhou E; Lachapelle P; Chemtob S
    Neonatology; 2011; 100(4):343-53. PubMed ID: 21968165
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranibizumab injection and laser photocoagulation to treat type 1 retinopathy of prematurity after 40 weeks post menstrual age: a retrospective case series study.
    Lyu J; Zhang Q; Chen C; Xu Y; Ji X; Zhao P
    BMC Ophthalmol; 2019 Feb; 19(1):60. PubMed ID: 30808338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cryotherapy of retinal prematurity in Denmark 1992-1996].
    Fledelius HC; Scherfig E
    Ugeskr Laeger; 1998 Jun; 160(25):3724-7. PubMed ID: 9641058
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Use of anti-VEGF (anti-vascular endothelial growth factor) in Retinopathy of Prematurity (ROP)].
    González Viejo I; Ferrer Novella C; Pueyo Royo V
    Arch Soc Esp Oftalmol; 2011 Jul; 86(7):207-8. PubMed ID: 21798405
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.